Isotretinoin, widely known by its former brand name Accutane, does interact with several hormonal systems in the body, though the effects vary by hormone and most appear to be modest and temporary. The drug is a derivative of vitamin A (a retinoid), and retinoid signaling touches enough biological pathways that a course of treatment can nudge thyroid markers, androgen metabolism, growth factors, and metabolic hormones in measurable ways. Whether those shifts matter clinically depends on which system you are looking at and how long the changes persist.
Thyroid Function Shows a Consistent Pattern
The most reproducible hormonal effect of isotretinoin is on the thyroid axis. In a prospective study of acne patients, TSH (the signal your pituitary sends to your thyroid) roughly doubled during treatment, climbing from an average of about 2.2 to about 4.1, while the thyroid hormones T3 and T4 both dropped significantly.1PubMed Central. Impact of isotretinoin therapy on thyroid hormone levels in acne vulgaris A separate study found the same directional shift: TSH up, free T3 and free T4 down, with thyroid gland volume also shrinking slightly during treatment.2PubMed. Effects of isotretinoin on the thyroid gland and thyroid function tests in acne patients
The important context here is that in most patients these changes stayed within or near the normal reference range. The pattern looks like what clinicians call subclinical hypothyroidism: the numbers move in a hypothyroid direction without crossing a threshold that produces obvious symptoms. Still, if you already have borderline thyroid function or a family history of thyroid disease, this is something worth flagging with your prescriber. Monitoring thyroid levels during a course of isotretinoin is something researchers in this area have started recommending, even though it is not yet universal practice.
Androgens in the Skin Versus the Bloodstream
One of the more interesting hormonal stories is what isotretinoin does to androgens, because it behaves differently at the skin level than in your general circulation. A study measuring skin androgen receptors in male acne patients found that isotretinoin did not change how tightly the receptor binds to hormones, but it reduced the total amount of androgen receptor in the skin by about 2.6-fold. Serum testosterone stayed the same, but levels of dihydrotestosterone (DHT) and its metabolites in the blood dropped.3PubMed. Effect of oral isotretinoin treatment on skin androgen receptor levels in male acneic patients An earlier study found the same pattern: no meaningful changes to precursor androgens, but reductions in DHT and the metabolite 3α-diol G in both men and women. Those researchers attributed the drop not to a direct hormonal effect but to isotretinoin’s dramatic shrinkage of the sebaceous glands, which normally contribute a portion of these tissue-derived androgens to the bloodstream.4Archives of Dermatology. Effect of Isotretinoin on Serum Levels of Precursor and Peripherally Derived Androgens in Patients With Acne
This distinction matters. When people ask whether isotretinoin “changes your hormones,” the answer for androgens is mostly no at the systemic level. Your ovaries or testes keep producing the same hormones. What changes is how aggressively your skin responds to them and how much androgen metabolite the skin itself releases. In women with acne treated with isotretinoin, one study found no significant effect on pituitary hormones, adrenal hormones, or insulin resistance.5PubMed. Evaluation of hirsutism and hormonal parameters in acne vulgaris patients treated with isotretinoin
A Special Case for Women with PCOS
Women with polycystic ovary syndrome (PCOS) sometimes get prescribed isotretinoin for severe acne that has not responded to other treatments, and the hormonal picture in this group is more notable. In one prospective study, isotretinoin treatment significantly reduced free testosterone levels, hirsutism scores, and ovarian volume on both sides, while also clearing acne as expected.6PubMed Central. The impact of oral isotretinoin on ovarian functions of acne patients complaining of polycystic ovarian syndrome A separate study in PCOS patients found similar results: decreased free testosterone, lower Ferriman-Gallwey scores (a measure of excess hair growth), reduced insulin levels, and bilaterally smaller ovaries after treatment, though triglycerides and cholesterol both rose.7PubMed Central. The Effects of Oral Isotretinoin in Women with Acne and Polycystic Ovary Syndrome
These findings are intriguing because the free testosterone reduction could be partly explained by the same sebaceous-gland mechanism discussed above: shrinking the glands removes a source of peripheral androgen metabolites. But the decrease in ovarian volume and insulin levels in one study hints at something more. Retinoic acid signaling is known to play a role in ovarian follicle development and steroid production, so it is plausible that isotretinoin influences these processes directly.8Reproductive Toxicology. Retinoic acid signaling in ovarian folliculogenesis and steroidogenesis Nobody is suggesting isotretinoin as a treatment for PCOS, but these secondary hormonal effects in PCOS patients are more pronounced than in women without the condition.
Male Fertility and Reproductive Hormones
Men taking isotretinoin sometimes worry about its effects on testosterone and fertility. The evidence here is fairly reassuring. A study tracking semen parameters before and after treatment found that semen volume, sperm concentration, total count, motility, and viability all improved significantly during treatment, though the percentage of normally shaped sperm declined slightly.9PubMed Central. Effect of systemic isotretinoin therapy on semen parameters Another study looking specifically at male fertility reported that all spermiogram parameters changed in a positive direction and that there was no significant change in hormone levels.10PubMed. The effect of systemic isotretinoin on male fertility
The slight worsening of sperm morphology deserves a mention. Whether that matters for real-world fertility is unclear because morphology is one of the most variable semen parameters to begin with, and the other measures all moved in a favorable direction. Men who are actively trying to conceive might want to discuss the timing of treatment with their dermatologist, but the overall picture is that isotretinoin does not tank male reproductive hormones.
Growth Factors and the Pituitary Question
Isotretinoin consistently lowers insulin-like growth factor 1 (IGF-1) and its binding protein IGFBP-3. One study found significant decreases in both after a short course of treatment, while growth hormone itself stayed stable.11PubMed. Short-term isotretinoin treatment decreases insulin-like growth factor-1 and insulin-like growth factor binding protein-3 levels Since IGF-1 is involved in cell growth and proliferation, and since acne-prone skin is influenced by IGF-1 signaling, this reduction may be part of how isotretinoin clears acne beyond just drying up sebum.
Where things get complicated is a Turkish study that reported significant decreases across a wide panel of pituitary and downstream hormones after three months of isotretinoin: LH, prolactin, total testosterone, ACTH, cortisol, IGF-1, IGFBP-3, growth hormone, and free T3 all fell.12PubMed. The effect of different doses of isotretinoin on pituitary hormones Taken at face value, this would mean isotretinoin broadly suppresses pituitary function. But other studies found no meaningful change in pituitary or adrenal hormones in women, and no change in reproductive hormone levels in men.13PubMed. Evaluation of hirsutism and hormonal parameters in acne vulgaris patients treated with isotretinoin14PubMed. The effect of systemic isotretinoin on male fertility The broad pituitary suppression reported in that single study has not been consistently replicated, so it is probably wise to treat those results with caution rather than assuming isotretinoin routinely crashes your cortisol and LH.
Insulin Resistance and Metabolic Signals
People on isotretinoin often notice changes in blood lipids, especially triglycerides, which is well established. But whether the drug actually shifts insulin resistance is a murkier question. One study reported a modest increase in HOMA-IR (a measure of insulin resistance) after five months of treatment, alongside changes in fat-derived signaling molecules called adipokines: resistin went down, retinol-binding protein 4 went up, while adiponectin and leptin stayed put.15PubMed Central. The effect of isotretinoin on insulin resistance and adipocytokine levels in acne vulgaris patients However, a systematic review and meta-analysis pooling data from multiple studies concluded that isotretinoin does not significantly alter insulin resistance overall, though it does raise serum adiponectin.16PubMed Central. The Effect of Isotretinoin on Insulin Resistance and Serum Adiponectin Levels in Acne Vulgaris Patients A separate study of women with severe acne similarly found that isotretinoin raised BMI and triglycerides but had no effect on androgens or insulin sensitivity.17PubMed. Insulin sensitivity, androgens and isotretinoin therapy in women with severe acne
The adipokine piece is worth noting even though it is unlikely to affect how you feel day to day. Another study found that both adiponectin and leptin levels rose significantly during treatment, while ghrelin (the “hunger hormone”) did not change.18PubMed Central. Effects of isotretinoin on body mass index, serum adiponectin, leptin, and ghrelin levels in acne vulgaris patients The rise in adiponectin is generally considered favorable since adiponectin improves insulin signaling, which may partly offset the triglyceride increase and the slight trend toward higher HOMA-IR seen in some individual studies. The overall synthesis: isotretinoin clearly pushes lipids around, but the evidence for lasting changes to how your body handles insulin is weak.
Vitamin D and Bone Turnover
One hormonal system that flies under the radar in conversations about isotretinoin is vitamin D. A prospective study measuring bone-related markers before and after three months of treatment found that 25-hydroxy vitamin D and serum calcium both dropped significantly, while the active form of vitamin D (1,25-dihydroxy vitamin D), parathyroid hormone, and bone alkaline phosphatase all rose.19PubMed. Does isotretinoin have effect on vitamin D physiology and bone metabolism in acne patients? The rise in parathyroid hormone is the body’s compensatory response to falling calcium: when calcium drops, parathyroid hormone climbs to pull more from bone and boost the conversion of vitamin D to its active form.
This pattern suggests that isotretinoin increases vitamin D turnover or clearance, forcing the parathyroid axis to work harder to maintain calcium balance. For a young adult on a standard course of treatment, this is unlikely to cause a problem. But for someone who is already vitamin D deficient, or who takes a longer or higher-dose course, the cumulative effect on bone metabolism is worth keeping in mind. Checking vitamin D levels before starting treatment is reasonable, and supplementing if you are low is a straightforward precaution.
Do These Hormonal Changes Reverse After Treatment?
The question most people really want answered is not just “does isotretinoin shift my hormones” but “will they go back to normal once I stop?” For the one system where the stakes feel highest, female ovarian reserve, a study tracked anti-Müllerian hormone (AMH), ovarian volume, and antral follicle count at the start of treatment, at six months (end of treatment), and again at 18 months (a year after stopping). At six months, all three markers had worsened significantly. By 18 months, they had returned to levels that were statistically similar to baseline.20PubMed. Long-term effect of systemic isotretinoin on female fertility
For thyroid markers, there is less formal follow-up data, but the subclinical nature of the shifts during treatment suggests they are unlikely to persist after the drug is cleared. Isotretinoin has a half-life of about one day, and its active metabolites wash out within a few weeks of stopping. Most of the hormonal studies measure effects during active treatment, which means the changes they report reflect the drug’s ongoing pharmacological action rather than permanent structural damage to glands.
Sexual Function and the Evidence Gap
Reports of decreased libido, erectile dysfunction, and vaginal dryness during isotretinoin treatment circulate widely in online forums, and some patients describe symptoms that persist after stopping the drug. When researchers tried to assess the evidence systematically through a scoping review covering 55 studies and over 2,400 patients, more than half of the studies found a beneficial or neutral effect on sexual function. The vast majority of the evidence was low quality, and the authors concluded there is very weak support for a causal link between isotretinoin and sexual dysfunction.21PubMed. Exploring the association between isotretinoin and sexual dysfunction
That does not mean nobody experiences sexual side effects. It means the available studies, most of which are observational and poorly controlled, cannot confidently separate isotretinoin’s role from other explanations like the psychological burden of severe acne, concurrent medications, or the nocebo effect of reading about side effects before starting. The hormonal pathways discussed above, particularly the drops in DHT metabolites and peripheral androgens, offer a plausible mechanism, but plausible and proven are different things. If you notice changes in sexual function during treatment, it is worth mentioning to your prescriber rather than dismissing or catastrophizing.
What Animal Studies Add to the Picture
One area that is hard to study in humans is how isotretinoin affects the brain’s own hormonal signaling. A recent mouse study found that chronic isotretinoin administration produced depressive and anxiety-like behaviors alongside measurable pathological changes in the hippocampus and prefrontal cortex. The researchers identified alterations in genes within a neuroactive signaling pathway and linked several metabolites, including taurine and adenosine, to the behavioral changes.22PubMed Central. Chronic administration of isotretinoin induces depressive- and anxiety-like behaviors by altering the neuroactive ligand-receptor interaction pathway in adolescent mice
Mice are not people, and a drug’s behavioral effects in rodents do not translate one-to-one to humans. But this study matters because it identifies specific molecular pathways in the brain that retinoid exposure can disrupt, which gives future researchers something concrete to look for in human subjects. The debate over whether isotretinoin causes depression has gone on for decades without resolution, in large part because large epidemiological studies have trouble disentangling the drug’s effects from the well-documented psychological toll of severe acne itself. Mechanistic work in animals does not settle that debate, but it keeps it scientifically grounded rather than purely anecdotal.
Why Isotretinoin’s Hormonal Reach Is So Broad
A reasonable question after reading all of this is: why does an acne drug touch so many hormonal systems at once? The answer lies in what isotretinoin actually is. It is a form of retinoic acid, and retinoic acid receptors are expressed in an unusually wide range of tissues, including the ovaries, the thyroid, the pituitary, the liver, bone, and the brain. The retinoid signaling system is not a narrow pathway like, say, a targeted cancer drug hitting one receptor. It is a fundamental developmental and regulatory system that influences gene expression across many cell types. Retinoic acid’s involvement in ovarian folliculogenesis and steroid production is one example of how deep this signaling runs.23Reproductive Toxicology. Retinoic acid signaling in ovarian folliculogenesis and steroidogenesis
This broad reach is also why the effects are generally small. Isotretinoin is not slamming any one hormonal axis the way, for instance, a corticosteroid suppresses your adrenal glands. It is gently nudging many systems simultaneously because it plugs into a signaling network that is everywhere. For most patients, those nudges are clinically insignificant and reversible. The exceptions, like patients with pre-existing thyroid problems or borderline ovarian reserve, are exactly the situations where awareness of these shifts can change how treatment is managed.